๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Renal Cancer

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 WIRE - Novel Treatments in Renal Cell Cancer NCT03741426Phase 27 sites๐Ÿ“ Cambridge๐Ÿ“ Edinburgh๐Ÿ“ Exeter CCTU- Cancer Theme ยท Tests: Olaparib, Cediranib, Volrustomig, Rilvegostomig Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell NCT07062549Phase 11 site๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: 111In-XYIMSR-01 Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer NCT04823923NA5 sites๐Ÿ“ Marseille๐Ÿ“ Montpellier๐Ÿ“ Montpellier Institut du Cancer de Montpellier - Val d'Aurelle ยท Tests: blood sampling for ITK dosage 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site๐Ÿ“ Beijing Peking University First Hospital ยท Tests: 18F-T2 PET/CT Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569Phase 24 sites๐Ÿ“ Atlanta๐Ÿ“ Atlanta๐Ÿ“ Atlanta Emory University ยท Tests: Biospecimen Collection, Computed Tomography, Enfortumab Vedotin, Magnetic Resonance Imaging, Pembrolizumab Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma NCT07067905EARLY Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: 68Ga-XT771 Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma NCT07223541Phase 21 site๐Ÿ“ Oklahoma City University of Oklahoma ยท Tests: Cemiplimab 350 MG Intravenous Solution, Fianlimab 1600 MG Intravenous Solution A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Urine biomarker -Guided without reTURBT A Study of Ward Admissions for Haematuria NCT07395037n/a1 site๐Ÿ“ London British Urology Researchers in Surgical Training ยท Tests: Inpatient work-up and management Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer NCT07234656n/a3 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Herning Brigitta Rasmussen Villumsen ยท Tests: Phase 1: Establishment of a patient-partner panel, Phase 2: Feasibility testing of FCR questions, mode of administratioโ€ฆ Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study NCT05361720Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Cleveland Vanderbilt-Ingram Cancer Center ยท Tests: Cabozantinib, Ipilimumab, Nivolumab Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527n/a1 site๐Ÿ“ Nanjing Jinling Hospital, China ยท Tests: Follow-up study of the treated cohort Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial NCT06720532n/a1 site๐Ÿ“ Munich Hannah Schaefer ยท Tests: characterization of renal function., Handgrip strength test, Questionaires Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Cabozantinib 80 MG VSV-IFNฮฒ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07510334Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Nivolumab Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct Carcinoma NCT06211114Phase 22 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University Cancer Hospital & Institute ยท Tests: PD-(L)1 inhibitor, Axitinib Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site๐Ÿ“ San Francisco Rahul Aggarwal ยท Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection Kidney Cancer DNA Registry NCT02087852n/a7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: salvia for germline DNA, the Kidney Cancer Questionnaire, Family History Questionnaire (when applicable), Blood draw, Eโ€ฆ Decision Aid (DA) for Renal Patients NCT05387863NA1 site๐Ÿ“ New York NYU Langone Health ยท Tests: Decision Aid (DA) Web Tool, Institutional Pamphlet Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer NCT07767500NA1 site๐Ÿ“ New York NYU Langone Health ยท Tests: MRI-guided linear accelerator, Magnetic resonance imaging (MRI)-guided radiation therapy (MRgRT) A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771Phase 18 sites๐Ÿ“ Hackensack๐Ÿ“ Allentown๐Ÿ“ Germantown Bristol-Myers Squibb ยท Tests: BMS-986488, Adagrasib, Cetuximab, Nivolumab Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform NCT06868927n/a1 site๐Ÿ“ Milan IRCCS San Raffaele DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Alectinib A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites๐Ÿ“ Clovis๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach Bristol-Myers Squibb ยท Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma NCT07688187Phase 11 site๐Ÿ“ Omaha PeptiDream Inc. ยท Tests: PD-32766D (a Copper-64 [64Cu] labeled peptide), PD-32766T (an Actinium-225 [225Ac] labeled peptide) uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto NCT05874921n/a22 sites๐Ÿ“ Santa Monica๐Ÿ“ Gainesville๐Ÿ“ Miami UroGen Pharma Ltd. ยท Tests: Jelmyto (mitomycin) for pyelocalyceal solution A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. NCT06903312Phase 41 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy